Air New Zealand Ltd (AIZ)
Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026
Key indicators
| Last close | AUD 0.310 |
|---|---|
| 52-week range | 0.300 – 0.550 |
| Return, 1 month / 3 months | −7.5% / −11.4% |
| Return, 1 year / 3 years | −40.4% / −44.6% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 34.3% |
| Worst drawdown (1 year) | -45.5% |
| Average daily value traded | 0.07M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Air New Zealand is the national airline of New Zealand, based in Auckland. It carries passengers on domestic routes within New Zealand and on international services linking the country with Australia, the Pacific, Asia, the Americas and Europe. The airline also transports cargo and runs a frequent-flyer programme. Its customers include leisure travellers, business passengers and freight shippers, and it operates a fleet of narrow-body and wide-body aircraft from its Auckland hub.
On this site Air New Zealand Ltd appears as a stock on the Australian Securities Exchange (Australia), code AIZ, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Air New Zealand Ltd (AIZ) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.310 on 20 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 847 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 40.4% and over the last three months it fell 11.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -17.7% | ||
| From 52-week high | -43.6% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.4% | ||
| 6-month return | -15.1% | ||
| 12-month return, skipping the last month | -35.6% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.5% | ||
| Liquidity | 58 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.07M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | −7.5% |
| 3 months | −11.4% |
| 6 months | −15.1% |
| 1 year | −40.4% |
| 3 years | −44.6% |
| 5 years | −62.4% |
Signals
| 50-day / 200-day average | 0.322 / 0.377 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.010 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Sep 2025 | NZD 0.0095 |
| 6 Mar 2025 | NZD 0.0096 |
| 12 Sep 2024 | NZD 0.0117 |
| 7 Mar 2024 | NZD 0.0158 |
| 7 Sep 2023 | NZD 0.0647 |
| 12 Mar 2020 | NZD 0.1053 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.